Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021

Publisher Name :
Date: 07-Oct-2016
No. of pages: 182
Inquire Before Buying

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, increasing investment in research related activities, and technological advancements are driving the growth in the global stem cell assay market. However, stringent regulatory policies and the high cost of stem cell based therapies are the major factors restraining the growth of this market.

The global stem cell assay market has been segmented on the basis of type of assay, kit, detection, instrument, application, end-user, and region. The viability/cytotoxicity segment is expected to account for the largest and fastest-growing segment of the global stem cell assay market in 2016. The increasing focus of the pharmaceutical industries on drug screening hasresulted in the increase in demand for stem cell assays.

Based on kits, the stem cell assay market is segmented into adult stem cell kits and human embryonic stem cell kits. The adult stem cell kits are segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits (IPSCs), hematopoietic stem cells kits, umbilical cord stem cell kits and neuronal stem cell kits. The adult stem cell kits segment is estimated to witness the highest CAGR during the forecast period, 2016 to 2021. The high growth in this segment is associated with the effectiveness of this type of kit in cellular analysis.

Based on detection, the global stem cell assay market has been segmented into instruments and detection kits. The instruments segment is anticipated to grow at the highest CAGR from 2016 to 2021. The high growth in this segment is due to the rising demand for instruments from the research and medical services.

On the basis application, the global stem cell assay market is segmented into regenerative medicine &therapy development, drug discovery and development and clinical research. The regenerative medicine &therapy development is further classified in to orthopedic &musculoskeletal spine, cardiovascular, oncology, central nervous system, dermatology, diabetes and others. Among the applications, the regenerative medicine &therapy development segment is projected to witness the highest growth rate during the forecast period owing to the increase in incidences of chronic diseases which resulted in the increased demand for regenerative medicines.

Geographically, the global stem cell assay market is dominated by North America, followed by Europe, the Asia-Pacific region, and the Rest of the World (RoW). Growth in the North American region is due to the increasing incidence and prevalence of chronic diseases and an increasing patient pool in North American countries.

The major players in the global stem cell assay market include GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (U.S.), Cell Biolabs, Inc. (U.S.), Hemogenix Inc. (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International, Inc. (U.S.).

Research Coverage:

This report aims to provide insights on the global stem cell assay market. It provides valuable information on the type of assay, kit, detection, instrument, application, end-user, and regional segments of the global stem cell assay market. The report also covers the market dynamics which includes the drivers, restraints, opportunities and challenges of the global stem cell assay market. This report covers the competitive landscape of the top ten companies in the global stem cell assay market. The competitive landscape includes a comparison between the companies and the strategies adopted by them in order to continue their presence in the global stem cell assay market.

Value Addition for the Buyer:

The above mentioned information would benefit buyers by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years.

In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the global stem cell assay market.

Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Lucrative Opportunities in the Global Stem Cells Market
4.2 Regional Analysis: Stem Cell Assay Market, By Kits, 2016

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Stem Cell Assay Market Segmentation, Assay Types
5.2.2 Stem Cell Assay Market Segmentation, By Kits
5.2.3 Stem Cell Assay Market Segmentation, By Application
5.2.4 Stem Cell Assay Market Segmentation, By End User
5.2.5 Stem Cell Assay Market Segmentation, By Region
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Investment in Research Related Activities
5.3.1.2 Technological Advancements
5.3.1.3 Funding for Stem Cell Research
5.3.2 Restraints
5.3.2.1 Affordability of Stem Cell Therapies & Treatments
5.3.2.2 Slow Response Time of Regulatory Bodies & Training Needs
5.3.3 Opportunities
5.3.3.1 Evolving Market & Fast Changing Market Dynamics
5.3.4 Challenges
5.3.4.1 Unapproved Stem Cell Operations

6 Stem Cell Assay Market, By Technology
6.1 Introduction
6.1.1 Technology Roadmap
6.1.2 Figure 1.1 Stem Cell Assay Market, By Technology
6.1.3 Micro Fabricated Assisted Technology
6.1.3.1 Microfluidics Based Cell Trap Technologies
6.1.4 Technology in Development

7 Stem Cell Assay Market, By Assay
7.1 Introduction
7.1.1 Cell Viability & Toxicity Assays
7.1.2 Isolation/Purification Assays
7.1.3 Cell Identification Assays
7.1.4 Cell Proliferation Assays
7.1.5 Cell Differentiation Assays
7.1.6 Cell Function Assays
7.1.7 Cell Apoptosis Assays

8 Stem Cell Assay Market, By Kits
8.1 Introduction
8.2 Adult Stem Cell Kits
8.2.1 Mesenchymal Stem Cell Kits
8.2.2 Induced Pluripotent Stem Cell Kits
8.2.3 Hematopoietic Stem Cell Kits
8.2.4 Neuronal Stem Cells Kits
8.2.5 Umbilical Cord Stem Cells
8.3 Human Embryonic Stem Cells Kits

9 Stem Cell Assay Market, By Product
9.1 Introduction
9.2 Figure 1.1 Stem Cell Assay Market, By Product
9.3 Instruments
9.3.1 Micro Electrode Arrays
9.3.2 Flow Cytometer
9.3.3 Cell Imaging Systems
9.3.4 Automated Cell Counter
9.4 Detection Kits
9.4.1 Immuno Histochemistry Kits

10 Stem Cell Assays Market, By Application
10.1 Introduction
10.2 Regenerative Medicine & Therapy Development
10.2.1 Orthopedic & Musculoskeletal Spine
10.2.2 Dermatology
10.2.3 Cardiovascular
10.2.4 Central Nervous System
10.2.5 Oncology
10.2.6 Diabetes
10.2.7 Others
10.3 Drug Discovery and Development
10.4 Clinical Research

11 Stem Cell Assays, By End User
11.1 Introduction
11.2 Research Institutes
11.3 Industry Research

12 Regional Analysis
12.1 Introduction
12.2 North America
12.3 Europe
12.4 Asia-Pacific
12.5 Rest of the World (RoW)

13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Situation and Trends
13.3.1 Approvals
13.3.2 Agreements, Partnerships & Collaborations
13.3.3 Acquisitions
13.3.4 Expansions
13.3.5 Other Developments

14 Company Profiles
14.1 Introduction
14.2 GE Healthcare
14.2.1 Business Overview
14.2.2 Company Snapshot GE Healthcare
14.2.3 Product Portfolio
14.2.4 Recent Developments
14.2.5 MnM View
14.3 Promega Corporation
14.3.1 Business Overview
14.3.2 Company Snapshot: Promega Corporation
14.3.3 Product Portfolio
14.3.4 Recent Developments
14.3.5 MnM View
14.4 Thermo Fisher Scientific Pvt. Ltd
14.4.1 Business Overview
14.4.2 Company Snapshot: Thermo Fisher Scientific
14.4.3 Product Portfolio
14.4.4 Recent Developments
14.4.5 MnM View
14.5 Merck Millipore
14.5.1 Business Overview
14.5.2 Company Snapshot: Merck Millipore
14.5.3 Product Portfolio
14.5.4 Recent Developments
14.5.5 MnM View
14.6 Cell Bio Labs, Inc.
14.6.1 Business Overview
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.6.4 MnM View
14.7 Hemogenix Inc.
14.7.1 Business Overview
14.7.2 Product Portfolio
14.7.3 Recent Developments
14.7.4 MnM View
14.8 Stem Cell Technologies
14.8.1 Business Overview
14.8.2 Product Portfolio
14.8.3 Recent Developments
14.8.4 MnM View
14.9 Bio Rad
14.9.1 Business Overview
14.9.2 Company Snapshot: Bio Rad
14.9.3 Product Portfolio
14.9.4 Recent Developments
14.9.5 MnM View
14.10 R&D Systems
14.10.1 Business Overview
14.10.2 Company Snapshot: R&D Sysytems
14.10.3 Product Portfolio
14.10.4 MnM View
14.11 Cellular Dynamics International.
14.11.1 Business Overview
14.11.2 Product Portfolio
14.11.3 Recent Developments
14.11.4 MnM View

15 Appendix
15.1 Insights From Industry Experts
15.2 Discussion Guide
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports

List of Tables

Table 1 Global Stem Cell Assay Market By Assat Types 2014 –2021 (USD Million)
Table 2 Cell Viability/Cytotoxicity Assay Market Size, By Region, 2014–2021 (USD Million)
Table 3 Isolation/Purification Assay Market Size, By Region, 2014–2021 (USD Million)
Table 4 Cell Identification Assay Market Size, By Region, 2014–2021 (USD Million)
Table 5 Cell Proliferation Assay Market Size, By Region, 2014–2021 (USD Million)
Table 6 Cell Differentiation Assay Market Size, By Region, 2014–2021 (USD Million)
Table 7 Cell Function Assay Market Size, By Region, 2014–2021 (USD Million)
Table 8 Cell Apoptosis Market Size, By Region, 2014–2021 (USD Million)
Table 9 Global Market Size, By Kits, 2014–2021 (USD Million)
Table 10 Global Adult Stem Cell Kits Market Size, By Types, 2014–2021 (USD Million)
Table 11 Mesenchymal Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 12 Induced Pluripotent Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 13 Hematopoietic Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 14 Neuronal Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 15 Umbilical Cord Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 16 Human Embryonic Stem Cell Kits Market Size, By Region, 2014–2021 (USD Million)
Table 17 Stem Cell Assay Product Market Size, By Product, 2014–2021 (USD Million)
Table 18 Stem Cell Assay Product Market Size, By Instruments, 2014–2021 (USD Million)
Table 19 Micro Electrode Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 20 Flow Cytometer Market Size, By Region, 2014–2021 (USD Million)
Table 21 Cell Imaging Market Size, By Region, 2014–2021 (USD Million)
Table 22 Automated Cell Counter Market Size, By Region, 2014–2021 (USD Million)
Table 23 Detection Kits Market Size, By Region, 2014–2021 (USD Million)
Table 24 Market Size, By Application, 2014–2021 (USD Million)
Table 25 Regenerative Medicine & Therapy Development Market Size, By Region, 2014–2021 (USD Million)
Table 26 Regenerative Medicine & Therapy Development Market Size, By Application, 2014–2021 (USD Million)
Table 27 Orthopaedic & Musculoskeleton Spine Market Size, By Region, 2014–2021 (USD Million)
Table 28 Dermatology Market Size, By Region, 2014–2021 (USD Million)
Table 29 Cardiovascular Market Size, By Region, 2014–2021 (USD Million)
Table 30 Central Nervous System Market Size, By Region, 2014–2021 (USD Million)
Table 31 Oncology Market Size, By Region, 2014–2021 (USD Million)
Table 32 Diabetes Market Size, By Region, 2014–2021 (USD Million)
Table 33 Others Market Size, By Region, 2014–2021 (USD Million)
Table 34 Others Market Size, By Region, 2014–2021 (USD Million)
Table 35 Others Market Size, By Region, 2014–2021 (USD Million)
Table 36 Market Size, By End User, 2014–2021 (USD Million)
Table 37 Market Size for Research Institutes, By Region, 2014–2021 (USD Million)
Table 38 Market Size for Research Institutes, By Region, 2014–2021 (USD Million)
Table 39 Market Size, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 41 North America: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 42 North America: Market Size, By Kits, 2014–2021 (USD Million)
Table 43 North America: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 44 North America: Market Size, By Detection, 2014–2021 (USD Million)
Table 45 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 46 North America: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 47 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 48 Viability/Cytotoxicity Type Expected to Lead the European Market,By Type in 2016
Table 49 Europe Market Size, By Assay Type, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Kits, 2014–2021 (USD Million)
Table 51 Europe: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 52 Europe: Market Size, By Detection, 2014–2021 (USD Million)
Table 53 Europe Market Size, By Application, 2014–2021 (USD Million)
Table 54 Europe: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 55 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 56 Asia Pacific: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 57 Asia Pacific: Market Size, By Kits, 2014–2021 (USD Million)
Table 58 Asia Pacific: Stem Cell Market Size, By Kits Under Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 59 North America: Market Size, By Detection, 2014–2021 (USD Million)
Table 60 Asia Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 61 Asia Pacific: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 62 Asia Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 63 Rest of the World: Market Size, By Assay Type, 2014–2021 (USD Million)
Table 64 Rest of the World: Market Size, By Kits, 2014–2021 (USD Million)
Table 65 Rset of the World : Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Table 66 Rest of the World: Market Size, By Detection, 2014–2021 (USD Million)
Table 67 Rest of the World: Market Size, By Application, 2014–2021 (USD Million)
Table 68 Rest of the World: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application 2014–2021 (USD Million)
Table 69 Rest of the World: Market Size, By End User, 2014–2021 (USD Million)
Table 70 Approvals, 2013–2016
Table 71 Agreements, Partnerships & Collaborations, 2013–2016
Table 72 Acquisitions, 2013–2016
Table 73 Expansions, 2013–2016

List of Figures

Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Type, 2016 vs 2021 (USD Million)
Figure 8 Global Market By Kits Segment 2016 vs 2021
Figure 9 Global Market By End 2016-2021
Figure 10 North America Led the Global Market in 2016
Figure 11 Global Stem Cells Assays Market to Witness High Growth During the Forecast Period
Figure 12 Mesenchymal Stem Cell Kits Dominated the Global Market, 2016
Figure 13 Viability/Cytotxicity Assay Market to Witness the Fastest Growth During the Forecast Period in the Market
Figure 14 North America to Witness the Fastest Growth During the Forecast Period
Figure 15 Market Segmentation
Figure 16 Market Segmentation, By Application
Figure 17 Market Segmentation, By End User
Figure 18 Market Segmentation, By Region
Figure 19 Drivers, Restraints, Opportunities, and Challenges
Figure 20 Global Market By Assat Types 2016 –2021 (USD Million)
Figure 21 North America to Account the Largest Share in Cell Viability/Toxicity Assay Market in 2016
Figure 22 North America to Account the Largest Share in Isolation/Purification Assay Market in 2016
Figure 23 North America to Account the Largest Share in Cell Identification Assay Market in 2016
Figure 24 North America to Account the Largest Share in Cell Proliferation Assay Market in 2016
Figure 25 North America to Account the Largest Share in Cell Differentiation Assay Market in 2016
Figure 26 North America to Account the Largest Share in Cell Function Assay Market in 2016
Figure 27 North America to Account the Largest Share in Cell Apoptosis Assay Market in 2016
Figure 28 Global Stem Cell Assay Market, By Kits, 2016 & 2021 (USD Million)
Figure 29 Global Adult Stem Cell Kits Market Size, By Types, 2014–2021 (USD Million)
Figure 30 North America to Account the Largest Share in Mesenchymal Stem Cell Kits Market in 2016
Figure 31 North America to Account the Largest Share in Induced Pluripotent Stem Cell Kits Market in 2016
Figure 32 North America to Account the Largest Share in Hematopoietic Stem Cell Kits Market in 2016
Figure 33 North America to Account the Largest Share in Neuronal Stem Cell Kits Market in 2016
Figure 34 North America to Account the Largest Share in Umbilical Cord Stem Cell Kits Market in 2016
Figure 35 North America to Account the Largest Share in Human Embryonic Stem Cell Kits Market in 2016
Figure 36 The Instrument Market Led the Stem Cell Assay By Product Market in 2015
Figure 37 Flow Cytometer Led the Stem Cell Assay By Instruments Market in 2016
Figure 38 North America Accounted for the Largest Share of the Micro Electrode in Stem Cell Assay By Product in 2016
Figure 39 North America Accounted for the Largest Share of the Flow Cytometer in Stem Cell Assay By Product in 2016
Figure 40 North America Accounted for the Largest Share of the Cell Imaging Systems in Stem Cell Assay By Product in 2016
Figure 41 North America Accounted for the Largest Share of the Automated Cell Counter in Stem Cell Assay By Product in 2016
Figure 42 North America Accounted for the Largest Share of the Detection Kits in Stem Cell Assay By Product in 2016
Figure 43 Regenerative Medicine & Therapy Development Market to Dominate the Stem Cell Assays Application Market in 2016
Figure 44 Regenerative Medicine & Therapy Development Market Size, By Region, 2014–2021 (USD Million)
Figure 45 Regenerative Medicine & Therapy Development Market Segmentation, By Application
Figure 46 Orthopaedic & Musculoskeleton Spine to Dominate the Regenerative Medicines Application Market in 2016
Figure 47 North America to Command the Largest Share of the Regenerative Medicine & Therapy Development Market for Orthopedic & Musculoskeletal Spine in 2016
Figure 48 North America to Dominate the Regenerative Medicines Market for Dermatology in 2016
Figure 49 North America is the Fastest Growing Region in the Regenerative Medicines Market for Cardiovascular Applications in 2016
Figure 50 North America to Dominate the Regenerative Medicine & Therapy Development Market for Central Nervous System Applications in 2016
Figure 51 North America is the Fastest Growing Region in the Regenerative Medicine & Therapy Development Market for Oncology Application
Figure 52 North America is the Fastest Growing Region in the Regenerative Medicine & Therapy Development Market for Diabetes Application
Figure 53 North America to Dominate the Regenerative Medicine & Therapy Development Market for Others Applications in 2016
Figure 54 North America to Dominate the Drug Discovery and Development Market in 2016
Figure 55 North America to Dominate the Clinical Research Market in 2016
Figure 56 Market Size, By End User, 2016 (USD Million)
Figure 57 North America to Dominate the Market for Research Institutes Between 2016 and 2021
Figure 58 North America to Dominate the Market for Industry Research Between 2016 and 2021
Figure 59 Market in North America to Grow at the Fastest Rate During the Forecast Period
Figure 60 North America: Market Snapshot
Figure 61 Viability/Cytotoxicity Type Expected to Lead the North American Market, in 2016
Figure 62 The Adult Stem Cell Kits are Expected to Dominate the North American Market, By Kits in 2016
Figure 63 North America Stem Cell Market Size, By Adult Stem Cell Kits, 2016–2021
Figure 64 Instruments to Dominate the North American Stem Cell Assay Detection Market in 2016
Figure 65 The Regenerative Medicine & Therapy Development to Dominate the North American Stem Cell Assay Market, By Application in 2016
Figure 66 North America: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 67 Industry Research is Estimated to Form the Largest Segment in the North American Stem Cell Assay Market, By End User in 2016
Figure 68 Europe: Stem Cell Assay Market Snapshot
Figure 69 Europe: Stem Cell Assay Market Size, By Country, 2014–2021 (USD Million)
Figure 70 The Adult Stem Cell Kits are Expected to Dominate the Europe Stem Cell Assay Market, By Kits in 2016
Figure 71 Europe: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 72 Instruments to Dominate the Europe Stem Cell Assay Market,By Detection in 2016
Figure 73 The Regenerative Medicine & Therapy Development to Dominate the North American Stem Cell Assay Market, By Application in 2016
Figure 74 Europe: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 75 Industry Research to Account for the Largest Share of the Stem Cell Assay End User Market in Europe
Figure 76 Asia-Pacific Stem Cell Assay Market Snapshot
Figure 77 Viability/Cytotoxicity Assay Expected to Lead the North American Stem Cell Assay Market,By Type in 2016
Figure 78 The Adult Stem Cell Kits are Expected to Dominate the Asia-Pacific Stem Cell Assay Market, By Kits in 2016
Figure 79 Asia Pacific: Stem Cell Market Size, By Kits Under Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 80 Instruments to Dominate the North American Stem Cell Assay Market,By Detection in 2016
Figure 81 The Regenerative Medicine & Therapy Development to Dominate the Asia Pacific Stem Cell Assay Market, By Application in 2016
Figure 82 Asia Pacific: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 83 Industry Research is Estimated to Form the Largest Segment in the North American Stem Cell Assay Market, By End User in 2016
Figure 84 Viability/Cytotoxicity Type Expected to Lead the Rest of the World Stem Cell Assay Market, By Type in 2016
Figure 85 The Adult Stem Cell Kits are Expected to Dominate the Rest of the World Stem Cell Assay Market, By Kits in 2016
Figure 86 Rest of the World: Stem Cell Market Size, By Adult Stem Cell Kits, 2014–2021 (USD Million)
Figure 87 Instruments to Dominate the Rest of the World Stem Cell Assay Market, By Detection in 2016
Figure 88 The Regenerative Medicine & Therapy Development to Dominate the Rest of the World Stem Cell Assay Market, By Application in 2016
Figure 89 Rest of the World: Stem Cell Market Size, Under Regenerative Medicine & Therapy Development Application, 2014–2021 (USD Million)
Figure 90 Industry Research is Estimated to Form the Largest Segment in the Rest of the World Stem Cell Assay Market, By End User in 2016
Figure 91 Companies Adopted Approvals as Their Key Growth Strategy Over the Last Three Years
Figure 92 Global Stem Cell Assay Market Share, By Key Player, 2015
Figure 93 Approvals: the Key Growth Strategy Adopted By Market Players From 2013 to 2015

  • Global Cancer Stem Cell Therapy Sales Market Report 2016
    Published: 30-Nov-2016        Price: US 4000 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Cancer Stem Cell Therapy Revenue, means the sales value of Cancer Stem Cell Therapy This report studies sales (consumption) of Cancer Stem Cell Therapy in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - AVIVA BioSciences Corporation - AdnaGen AG - Adva......
  • United States Mesenchymal Stem Cell Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 113
    Notes: Sales, means the sales volume of Mesenchymal Stem Cell Revenue, means the sales value of Mesenchymal Stem Cell This report studies sales (consumption) of Mesenchymal Stem Cell in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Biomet, Inc. (US) - Bioventus LLC (US) - DePuy Synthes Companies (US) - DePuy Spine, Inc. (US) - Exactech, Inc. (US) - Hi......
  • Global Cancer Stem Cell Therapy Market Research Report 2016
    Published: 28-Nov-2016        Price: US 2900 Onwards        Pages: 109
    Notes: Production, means the output of Cancer Stem Cell Therapy Revenue, means the sales value of Cancer Stem Cell Therapy This report studies Cancer Stem Cell Therapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - AVIVA BioSciences Corporation - AdnaGen AG - Advanced Cel......
  • Global Cancer Stem Cell Therapy Market Professional Survey Report 2016
    Published: 23-Nov-2016        Price: US 3500 Onwards        Pages: 106
    Notes: Production, means the output of Cancer Stem Cell Therapy Revenue, means the sales value of Cancer Stem Cell Therapy This report studies Cancer Stem Cell Therapy in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, ......
  • Global Mesenchymal Stem Cells Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 19-Nov-2016        Price: US 3480 Onwards        Pages: 102
    Mesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types, including: osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells).Scope of the Report:This report focuses on the Mesenchymal Stem Cells in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, r......
  • Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts
    Published: 01-Nov-2016        Price: US 2995 Onwards        Pages: 370
    "Delivery of this report will take 1-3 days after purchase." The Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in stem cell partnering Deal terms analysis Partnering agreement structure Partnering contract docu......
  • Global Hematopoietic Stem Cell Market Research Report 2021
    Published: 18-Aug-2016        Price: US 2900 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Hematopoietic Stem Cell Revenue, means the sales value of Hematopoietic Stem Cell This report studies Hematopoietic Stem Cell in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering - Neuralstem - NeuroNova AB - NeuroGeneration - StemCells......
  • Global Human Embryonic Stem Cell Market Research Report 2021
    Published: 18-Aug-2016        Price: US 2900 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Human Embryonic Stem Cell Revenue, means the sales value of Human Embryonic Stem Cell This report studies Human Embryonic Stem Cell in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering - Neuralstem - NeuroNova AB - NeuroGeneration - StemC......
  • Global Neural Stem Cell Market Research Report 2021
    Published: 18-Aug-2016        Price: US 2900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Neural Stem Cell Revenue, means the sales value of Neural Stem Cell This report studies Neural Stem Cell in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering - Neuralstem - NeuroNova AB - NeuroGeneration - StemCells - ReNeuron Limi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs